Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 2||- / OT|
Administered by: Other Purchased by: ??
Symptoms: General physical health deterioration
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': DEPFIZER INC2021164500
Write-up: General physical health deterioration; This is a spontaneous report from a non-contactable physician downloaded from the Medicines Agency (MA) Regulatory Authority-WEB, Regulatory Authority number DE-PEI-PEI2021002561. A 98-year-old male patient received the second dose bnt162b2 (COMIRNATY), intramuscular on 03Feb2021 at SINGLE DOSE for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient previously received the first dose bnt162b2 (COMIRNATY) in Jan2021 for covid-19 immunization, and had been tolerated. On 05Feb2021 after vaccination the patient developed general physical health deterioration, lasting for 5 days. No treatment, no hospitalization. The patient died in Feb2021. It was not reported if an autopsy was performed. The outcome of event general physical health deterioration was fatal. Event Assessment: For both events / RA / D. Unclassifiable. No follow-up attempts possible, batch/lot number cannot be obtained.; Reported Cause(s) of Death: General physical health deterioration
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166